Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Kenmerkende hersenontstekingen gelinkt aan ernstiger beloop MS
mei 2025 | Multipele Sclerose